Prices as of 2026/10/30 close
Company comparison
NSSOL is the bigger company, with revenue of ¥381.3B — 18.3x Broadleaf's ¥20.8B.
NSSOL earns more on each yen of sales, with an operating margin of 11.6% — 1.7 points above Broadleaf (9.9%).
Revenue growth in the latest results: Broadleaf +15.4%, NSSOL +12.7%. For next year, Broadleaf guides for the fastest operating profit growth (+132.7%).
NSSOL pays more on average — ¥9.06M against ¥6.47M at Broadleaf.
Over the past year the shares moved Broadleaf +33.4%, NSSOL +10.3%.
Head-to-head wins15 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
NSSOL aheadNSSOL 3 : Broadleaf 0
Revenue: NSSOL ¥381.3B / Broadleaf ¥20.8B
ProfitabilityInvestors
NSSOL aheadNSSOL 3 : Broadleaf 0
Operating margin: NSSOL 11.6% / Broadleaf 9.9%
GrowthInvestors
Broadleaf aheadNSSOL 0 : Broadleaf 4
Revenue growth (YoY): NSSOL +12.7% / Broadleaf +15.4%
Stock & balance sheetInvestors
Broadleaf aheadNSSOL 0 : Broadleaf 2
Share price, 1 year: NSSOL +10.3% / Broadleaf +33.4%
Pay & workforceJob seekers
NSSOL aheadNSSOL 2 : Broadleaf 1
Average salary: NSSOL ¥9.06M / Broadleaf ¥6.47M
| Metric | NSSOL | Broadleaf | Gap |
|---|---|---|---|
| Revenue | ◎¥381.3B | ¥20.8B | 18.3x |
| Operating profit | ◎¥44.2B | ¥2.1B | 21.4x |
| Net income | ◎¥30.8B | ¥1.2B | 24.9x |
| Metric | NSSOL | Broadleaf | Gap |
|---|---|---|---|
| Operating margin | ◎11.6% | 9.9% | 1.7pt |
| Net margin | ◎8.1% | 6.0% | 2.1pt |
| ROE | — | 5.2% | |
| Revenue per employee | ◎¥97M | ¥29M | 3.4x |
| Metric | NSSOL | Broadleaf | Gap |
|---|---|---|---|
| Revenue growth (YoY) | +12.7% | ◎+15.4% | 2.7pt |
| Operating profit growth (YoY) | +14.9% | ◎+206.0% | 191.1pt |
| Revenue CAGRlast 5 years | +8.6% | — | |
| Guidance: revenue growthnext FY plan | +9.4% | ◎+12.9% | 3.5pt |
| Guidance: op. profit growthnext FY plan | +7.4% | ◎+132.7% | 125.3pt |
| Metric | NSSOL | Broadleaf | Gap |
|---|---|---|---|
| Share price, 1 year | +10.3% | ◎+33.4% | 23.2pt |
| Share price, 3 months | +5.2% | ◎+6.0% | 0.8pt |
| P/E (trailing)lower = cheaper | — | 34.7x | |
| Equity ratio | — | 58.6% | |
| Share price (close) | ¥4,136 | ¥479 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | NSSOL | Broadleaf | Gap |
|---|---|---|---|
| Average salary | ◎¥9.06M | ¥6.47M | ¥2.58M |
| Starting salary (monthly) | ◎¥263,000 | ¥219,000 | ¥44,000 |
| Average tenure | 12.6 yrs | ◎13.4 yrs | 0.8 |
| Average age | 39.9 | 46.6 | 6.7 |
| Employees | 3,938 | 723 | 5.4x |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥4,136+10.3% (1Y)
NSSOL +10.3% over 1Y. Compared: Broadleaf +33.4%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
NSSOL2 segments
Broadleaf3 segments
AAverage annual salary from the securities filings: NSSOL ¥9.06M, Broadleaf ¥6.47M. NSSOL pays the most. Averages also depend on staff age and job mix, so check the average age too (NSSOL 39.9, Broadleaf 46.6).
ARevenue in the latest results: NSSOL ¥381.3B, Broadleaf ¥20.8B. NSSOL is the bigger company, with revenue of ¥381.3B — 18.3x Broadleaf's ¥20.8B.
AOperating margins: NSSOL 11.6%, Broadleaf 9.9%. NSSOL turns the highest share of sales into operating profit.
AShare price change over the past year (closing prices, for reference): Broadleaf +33.4%, NSSOL +10.3%. Broadleaf has risen the most.
Comparing 2 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.
